» Articles » PMID: 32333760

High Rates of Recurrent Tuberculosis Disease: A Population-level Cohort Study

Overview
Journal Clin Infect Dis
Date 2020 Apr 26
PMID 32333760
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Retreatment tuberculosis (TB) disease is common in high-prevalence settings. The risk of repeated episodes of recurrent TB is unknown. We calculated the rate of recurrent TB per subsequent episode by matching individual treatment episodes over a period of 13 years.

Methods: All recorded TB episodes in Cape Town between 2003 and 2016 were matched by probabilistic linkage of personal identifiers. Among individuals with a first episode notified in Cape Town and who completed their prior treatment successfully we estimated the recurrence rate stratified by subsequent episode and HIV status. We adjusted person-time to background mortality by age, sex, and HIV status.

Results: A total of 292 915 TB episodes among 263 848 individuals were included. The rate of recurrent TB was 16.4 per 1000 person-years (95% CI, 16.2-16.6), and increased per subsequent episode (8.4-fold increase, from 14.6 to 122.7 per 1000 from episode 2 to 6, respectively). These increases were similar stratified by HIV status. Rates among HIV positives were higher than among HIV negatives for episodes 2 and 3 (2- and 1.5-fold higher, respectively), and the same thereafter.

Conclusions: TB recurrence rates were high and increased per subsequent episode, independent of HIV status. This suggests that HIV infection is insufficient to explain the high burden of recurrence; it is more likely due to a high annual risk of infection combined with an increased risk of infection or progression to disease associated with a previous TB episode. The very high recurrence rates would justify increased TB surveillance of patients with >1 episode.

Citing Articles

Recurrent Pulmonary Tuberculosis in China, 2005 to 2021.

Li T, Zhang B, Du X, Pei S, Jia Z, Zhao Y JAMA Netw Open. 2024; 7(8):e2427266.

PMID: 39133484 PMC: 11320166. DOI: 10.1001/jamanetworkopen.2024.27266.


Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study.

Kim M, Kim Y, Jeong D, Kim S, Hong S, Park S Therap Adv Gastroenterol. 2024; 17:17562848241265013.

PMID: 39092170 PMC: 11292712. DOI: 10.1177/17562848241265013.


Post-tuberculosis treatment paradoxical reactions.

Hermans S, Akkerman O, Meintjes G, Grobusch M Infection. 2024; 52(5):2083-2095.

PMID: 38955990 PMC: 11499416. DOI: 10.1007/s15010-024-02310-0.


Time until tuberculosis recurrence and associated factors in Brazil: a populationbased retrospective cohort study using a linked database.

Pelissari D, Lima L, Pavinati G, Magnabosco G, de Barros Silva Junior J, Bartholomay P Rev Bras Epidemiol. 2024; 27:e240016.

PMID: 38655945 PMC: 11027432. DOI: 10.1590/1980-549720240016.


Role of B Cells in Mycobacterium Tuberculosis Infection.

Stewart P, Patel S, Comer A, Muneer S, Nawaz U, Quann V Vaccines (Basel). 2023; 11(5).

PMID: 37243059 PMC: 10222439. DOI: 10.3390/vaccines11050955.


References
1.
Sonnenberg P, Murray J, Glynn J, Shearer S, Kambashi B, Godfrey-Faussett P . HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001; 358(9294):1687-93. DOI: 10.1016/S0140-6736(01)06712-5. View

2.
Moller M, Kinnear C, Orlova M, Kroon E, van Helden P, Schurr E . Genetic Resistance to Infection and Disease. Front Immunol. 2018; 9:2219. PMC: 6170664. DOI: 10.3389/fimmu.2018.02219. View

3.
Panjabi R, Comstock G, Golub J . Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007; 11(8):828-37. View

4.
Lonnroth K, Jaramillo E, Williams B, Dye C, Raviglione M . Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009; 68(12):2240-6. DOI: 10.1016/j.socscimed.2009.03.041. View

5.
Charalambous S, Grant A, Moloi V, Warren R, Day J, van Helden P . Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2008; 12(8):942-8. View